Nick Muscato - 21 Nov 2022 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Strategy Officer
Signature
Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
21 Nov 2022
Net transactions value
$0
Form type
4
Filing time
23 Nov 2022, 16:23:24 UTC
Previous filing
27 Jul 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +11,555 +431% $0.000000 14,238 21 Nov 2022 Direct F1
holding AMED Common Stock 213 21 Nov 2022 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 11,555 time-based restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 50% installments on each of November 21, 2025 and November 21, 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The information in this report is based on a plan statement dated as of September 30, 2022.